This is educational information, not medical advice, and The Peptide University does not sell peptides, supplies, or supplements. Many compounds discussed here are sold as “research chemicals” and are not approved for human use outside of clinical trials. Laws vary by country, and nothing here is a recommendation to obtain or use anything. Talk to a qualified clinician about your own situation.
Melanotan II is a synthetic, cyclic analogue of alpha-MSH used to stimulate tanning. It is not approved by the FDA (or as a medicine generally) and has documented safety concerns.
How it works
Unlike the selective afamelanotide, melanotan II is non-selective — it activates MC1R (pigmentation) but also MC3R, MC4R, and MC5R, which is why it also affects appetite and sexual function (MC4R) alongside tanning.
The evidence
It does stimulate pigmentation, but its broad receptor activity produces off-target effects that early human studies documented and that were never resolved into a safe, approved product.
Safety
Reported concerns include nausea, flushing, sexual side effects, blood-pressure changes, and darkening/changes in moles — and mole changes are a reason dermatologists urge caution (monitoring skin lesions). Non-sterile injection adds infection risk. This is a widely cautioned-against compound.
FAQ
QHow is it different from afamelanotide?
Afamelanotide is selective for MC1R and FDA-approved for a rare condition; melanotan II is non-selective, unapproved, and carries more side effects.
QWhy do dermatologists warn about it?
Beyond the central side effects, it can change moles/skin lesions, which complicates skin-cancer monitoring.
Sources
This profile summarizes the following. Follow the links to read the originals — and remember that summaries age, so check for newer information.
Inclusion here is not endorsement of any source's claims; several are cited so you can compare how different outlets characterize the same evidence.
Questions & comments
No account, no login — leave a name or stay anonymous. Ask a question, add something the article missed, or answer someone else. Be kind and cite sources where you can.